IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new muscle disease drug begins
Disease control Not yet recruitingThis is the first study in humans to test the safety and side effects of a new drug called XmAb657. It will involve both healthy volunteers and people with idiopathic inflammatory myopathy, a group of rare autoimmune diseases that cause muscle inflammation and weakness. Participa…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Massive study launches to track mysterious brain and nerve attacks
Knowledge-focused Not yet recruitingThis study aims to observe and understand how a group of related autoimmune diseases that attack the brain, nerves, and muscles progress over time in real-world patients. It will follow 1,550 adults diagnosed with conditions like multiple sclerosis, myasthenia gravis, and autoimm…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC